NCT06345560 Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
| NCT ID | NCT06345560 |
| Status | Recruiting |
| Phase | Phase 1, Phase 2 |
| Sponsor | Chulalongkorn University |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-04-18 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 16 participants in total. It began in 2024-04-18 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate whether bariatric surgery affects Drospirenone only pills absorption
Eligibility Criteria
Inclusion Criteria: * Thai women aged 18-45 years who are obese and had an appointment for Bariatric surgery at Chulalongkorn Hospital * Need contraception * Able to use non-hormonal contraception during the study * Giving consent Exclusion Criteria: * Pregnancy or history of giving birth within 3 months * Breastfeeding within the 6 months * History of using DMPA within 12 months * History of using other types of hormonal birth control pills within 4 weeks * History of bilateral oophorectomy or hysterectomy * Suspected ovarian tumor or pathological ovarian cyst * Regular cigarette smoking * Contraindications to Drospirenone
Contact & Investigator
Punyawee Utaipatanacheep
PRINCIPAL INVESTIGATOR
Chulalongkorn University
Frequently Asked Questions
Who can join the NCT06345560 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06345560 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT06345560 currently recruiting?
Yes, NCT06345560 is actively recruiting participants. Contact the research team at punyawee@docchula.com for enrollment information.
Where is the NCT06345560 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT06345560 clinical trial?
NCT06345560 is sponsored by Chulalongkorn University. The principal investigator is Punyawee Utaipatanacheep at Chulalongkorn University. The trial plans to enroll 16 participants.